Stem Cells and the FDA

The Manhattan Regenerative Medicine Medical Group is involved with the Investigational use of Autologous Adipose Derived Stem Cells (ADSCs) for clinical research and deployment.

The Manhattan Regenerative Medicine Medical Group is offering patient-funded research to treat individuals with autologous (their own) fat-derived stem cells and are not involved in the use ormanufacturing of any investigational drugs or devices.

The Manhattan Regenerative Medicine Medical Group is not offering stem cell therapy as a cure for any condition, disease, or injury.

No statements or treatments on this website have been evaluated or approved by the FDA.

This website contains no medical advice.

All statements and opinions on this website are provided for educational and informational purposes only.

We do not diagnose or treat via this website or via telephone.

The Manhattan Regenerative Medicine Medical Group does not claim that any applications, or potential applications, using autologous adult stem cell treatments are approved by the FDA, or are even effective.

We do not claim that these treatments work for any listed nor unlisted condition, intended or implied.

It is important for potential patients to do their own research based on the options that we present so they can make informed decisions.

See the article here:
Stem Cells and the FDA